sample 2.jpg
Nutrition

Prebiotics

By the a2™ Careline Team, The a2 Milk Company
First published 15 Jan 2026
Last Updated 15 Jan 2026
Next review Jan 2027
Peer reviewed by:
the a2™ Careline Team, The a2 Milk Company

Key takeaways

  • Prebiotics are non-digestible food components that feed beneficial gut bacteria (especially Bifidobacteria); they differ from probiotics, which are the live bacteria themselves.
  • Breast milk contains natural prebiotics (HMOs); some infant formulas add GOS and/or FOS, which can shift the infant microbiome closer to that of breastfed babies.
  • Supplemented formula is unlikely to fully match the diversity of HMOs in breast milk, but may be a better option than standard formula when breastfeeding isn’t possible.

Prebiotics are non-digestible food components that have the ability to enhance the growth and/or activity of some beneficial bacteria. Prebiotics are sometimes confused with probiotics, which are live beneficial bacteria. Instead, prebiotics encourage the growth and activity of these same bacteria already existing in the gut. Prebiotics are mostly found in plant-based foods including bananas, asparagus, onion and artichoke.


General health

In adults, prebiotic supplementation may benefit gut health by reducing IBS symptoms and the risk of contracting traveller’s diarrhoea.(1, 2) In one study, prebiotic intake was associated with positive immune effects including increased phagocytosis, natural killer cell activity, and production of anti-inflammatory interleukin-10 (IL-10).(3) In the same study, researchers found it also reduced the production of pro-inflammatory cytokines (IL-6, IL-1 and tumour necrosis factor-α).(3) The beneficial effects of prebiotics are most likely secondary to the increase in Bifidobacteria spp. that follows supplementation. Bifidobacteria are well-recognised beneficial bacteria that play an important role in the gut microbiome. Low levels of Bifidobacteria in the gut are associated with several health conditions including coeliac disease, irritable bowel syndrome, allergies, and metabolic syndrome.(4-7)


Prebiotics in infant formula

Human breast milk contains natural prebiotics called human milk oligosaccharides (HMOs). They are the third largest component of human milk and promote healthy development of the infant’s microbiome. Dietary oligosaccharides that have similar prebiotic effects to HMOs include galacto-oligosaccharides (GOS), fructo-oligosaccharides (FOS), and pectin-derived acidic oligosaccharides. GOS and FOS are found in the non-digestible components of foods, commonly including legumes, wheat and rye products, onion and garlic. Since HMOs, GOS and FOS are not actually digested, they pass through to the colon where they have beneficial effects.

The composition of breast milk is still not entirely understood in scientific literature, but there have been significant breakthroughs in finding key components that benefit developing infants. Infant formulas are constantly being reformulated in response to these discoveries with the aim of providing similar benefits to breast milk. For example, some infant formulas are now supplemented with prebiotic GOS, FOS, or both. Additionally, certain HMOs, structurally identical to those found in breast milk, are available to add to infant formula products.(8) While over 200 different HMOs have been identified in breast milk, only a limited number have been approved for use in infant formula in Australia.

Studies comparing the effects of GOS- and FOS-supplemented infant formula with standard infant formula have demonstrated beneficial effects of these prebiotics.

Infants given formula supplemented with GOS or FOS show signs of improved gastrointestinal health compared with those fed non-supplemented formula.(9) These benefits can include changes in short-chain fatty acids, lactate and pH that more closely resemble the fermentation profile observed in breastfed infants.(9) Those fed supplemented formula also had higher levels of Bifidobacterium spp. compared with infants fed standard formula.(1, 9-14) Bifidobacteria reduce the amount of pathogens in faecal flora and may provide some protection against intestinal infections in infants.(15)

Some studies have found a dose-dependent relationship between the amount of GOS and/or FOS in infant formula and softer stools that are more similar to breastfed infants.(10, 12) Compared with other prebiotics, GOS is generally best tolerated and results in only a small amount of gas production.(14) It is important to note that beneficial effects of GOS-supplemented infant formula may only be seen when administration commences in the first few months of life.(16) The effects may also be short-term, as bacterial populations return to baseline levels one to two weeks after GOS consumption ceases.(11)

A Cochrane review found that formula-fed infants were less likely to develop eczema if their formula contained prebiotics; however, this did not extend to asthma or hives.(17) There are fewer Bifidobacteria and more clostridia and Staphylococcus aureus in the microbiome of infants who develop allergies later in life.(18) There is significant evidence that the microbiome is related to immune function. As scientific understanding of this relationship improves, it may become possible to manipulate the microbiome for immune benefits.(18, 19) But further research is needed before recommending prebiotics for allergy prevention in infants.


Breastfeeding

Infant formula supplemented with GOS and/or FOS is unlikely to provide equal benefits to HMOs naturally in breast milk. Even with the addition of structurally identical HMOs, infant formula cannot fully replicate the diversity and complexity of the variety of HMOs in breast milk.(8) It is well understood that breast milk provides the best nutrition for infants. But when breastfeeding is not possible, infant formula supplemented with prebiotics may be a better option than standard formulas. The current literature suggests that infants consuming supplemented formulas have similar colonic microbial environments to that in breastfed infants.(1, 9-14) Whether breastfeeding or formula-feeding, the developing baby will ultimately consume naturally occurring prebiotics when they commence intake of solids.


References

  1. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508–18.
  2. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr. 2010;64(2):146–52.
  3. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008;88(5):1438–46.
  4. Quagliariello A, Aloisio I, Bozzi Cionci N, Luiselli D, D’Auria G, Martinez-Priego L, et al. Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. Nutrients. 2016;8(10):660.
  5. Bu Z, Ye X, Huang B, Liu R, Peng L. Bifidobacteria Was Decreased in Adult Patients With Irritable Bowel Syndrome Based on PCR and Bacterial Culture: A Systematic Review and Meta-Analysis. Turk J Gastroenterol. 2022;33(5):368–76.
  6. Jarman JB, Torres PJ, Stromberg S, Sato H, Stack C, Ladrillono A, et al. Bifidobacterium deficit in United States infants drives prevalent gut dysbiosis. Communications Biology. 2025;8(1):867.
  7. Luangphiphat W, Prombutara P, Jamjuree P, Chantarangkul C, Vitheejongjaroen P, Muennarong C, et al. The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of metabolic syndrome: a randomized, double-blinded, placebo-controlled study. PLOS ONE. 2025;20(1):e0317202.
  8. Wichmann A. Biological effects of combinations of structurally diverse human milk oligosaccharides. Front Pediatr. 2024;12:1439612.
  9. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40(1):36–42.
  10. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291–5.
  11. Davis LM, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One. 2011;6(9):e25200.
  12. Ashley C, Johnston WH, Harris CL, Stolz SI, Wampler JL, Berseth CL. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J. 2012;11:38.
  13. Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, et al. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2012;36(1 Suppl):95s–105s.
  14. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol. 2001;91(5):878–87.
  15. Knol J, Boehm G, Lidestri M, Negretti F, Jelinek J, Agosti M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr Suppl. 2005;94(449):31–3.
  16. Nakamura N, Gaskins HR, Collier CT, Nava GM, Rai D, Petschow B, et al. Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. Appl Environ Microbiol. 2009;75(4):1121–8.
  17. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev. 2013;(3):CD006474.
  18. Notarbartolo V, Carta M, Accomando S, Giuffrè M. The First 1000 Days of Life: How Changes in the Microbiota Can Influence Food Allergy Onset in Children. Nutrients. 2023;15(18):4014.
  19. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108(4):516–20.

Breastfeeding Reminder

Breast milk is best for babies. The a2 Milk Company® supports exclusive breastfeeding for the first six months and continued breastfeeding for as long as mother and child desire. Responsive cue based feeding applies to breast  and formula fed infants alike.

Share

careline image.webp

Get Expert Support

Our a2™ Careline is supported by Accredited Practising Dietitians ready to help answer your questions.